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Abstract 
Formation, maintenance, and repair of the blood–brain barrier (BBB) are critical for central nervous system homeo-
stasis. The interaction of endothelial cells (ECs) with brain pericytes is known to induce BBB characteristics in brain 
ECs during embryogenesis and can be used to differentiate human ECs from stem cell source in in vitro BBB models. 
However, the molecular events involved in BBB maturation are not fully understood. To this end, human ECs derived 
from hematopoietic stem cells were cultivated with either primary bovine or cell line-derived human brain pericytes 
to induce BBB formation. Subsequently, the transcriptomic profiles of solocultured vs. cocultured ECs were analysed 
over time by Massive Analysis of cDNA Ends (MACE) technology. This RNA sequencing method is a 3′-end targeted, 
tag-based, reduced representation transcriptome profiling technique, that can reliably quantify all polyadenylated 
transcripts including those with low expression. By analysing the generated transcriptomic profiles, we can explore 
the molecular processes responsible for the functional changes observed in ECs in coculture with brain pericytes 
(e.g. barrier tightening, changes in the expression of transporters and receptors). Our results identified several up- 
and downregulated genes and signaling pathways that provide a valuable data source to further delineate complex 
molecular processes that are involved in BBB formation and BBB maintenance. In addition, this data provides a source 
to identify novel targets for central nervous system drug delivery strategies.
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Background
Brain capillary endothelial cells (ECs) display unique 
characteristics when compared to ECs from peripheral 
vasculature, e.g. tight junctions, low pinocytic activity, 
expression of metabolic enzymes, transporters, receptors 
and efflux pumps [24]. These characteristics are known to 
be the blood-brain barrier (BBB) phenotype which con-
stitute the BBB [2, 11]. The BBB is the interface between 
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the systemic circulation and the central nervous system 
and is essential to maintain brain homeostasis, thereby 
restricting the entry of many pathogens, toxins and com-
pounds into the brain [1]. Several of these brain capillary 
EC characteristics mentioned above are demonstrated 
not to be intrinsic to brain ECs, however, they result from 
the regulation of cellular and non-cellular factors pro-
duced by different cell types of the neurovascular unit 
(NVU), e.g. astrocytes, pericytes, neurons, neuroglia and 
peripheral immune cells [9, 11, 30]. The specific cross-
talk between brain ECs and brain pericytes is known to 
induce BBB characteristics (e.g. expression and func-
tionality of tight junction proteins, decreasing leukocyte 
adhesion molecule expression, decreasing transcytosis 
and induction of the basement membrane) in ECs dur-
ing embryogenesis in  vivo [11, 30]. Pericytes are a type 
of vascular cells embedded in the basement membrane, 
thereby they wrap the cerebral capillary walls, with a 
pericyte coverage being the highest in neural tissue [30]. 
The latter implicates the importance of pericytes for 
BBB functioning, which is as well indicated by studies 
that relate pericytes to barrier function and regulation 
of inflammatory responses [9, 22]. The pericyte-brain EC 
interaction is also used to differentiate ECs from stem cell 
source to human brain-like ECs which are used in in vitro 
BBB models [7, 21, 23, 36]. These in vitro models should 
display barrier tightening, i.e. induced by coculture, in 
order to be of use for pharmaceutical screening. How-
ever, the underlying molecular events involved in devel-
opment, maturation and maintenance of BBB features, 
are not fully understood and difficult to study in  vivo, 
especially in humans. In particular, the BBB regulation 
related to the communication between pericytes and 
brain ECs remains largely unknown [5, 15, 22].
In the present study, we make use of a human in vitro 
BBB model developed by Cecchelli et al. [7] consisting in 
ECs derived from hematopoietic stem cells which are co-
cultivated with brain pericytes. After 5 days of coculture 
with brain pericytes, the ECs were shown to display fea-
tures of the BBB which were absent when the cells were 
cultivated alone: the co-cultivated ECs display a continu-
ous expression of ZO-1, occludin, JAM-A, claudin-1 and 
claudin-5 at cell–cell contacts resulting in a lower perme-
ability to non-permeant marker than when the cells were 
solocultivated. These cocultivated ECs also express sev-
eral transporters typically observed in brain endothelium 
in vivo (e.g. ABCB1 and ABCG2) [7].
To study the molecular processes responsible for the 
observed changes in ECs (i.e. barrier tightening, changes 
in the expression of transporters and receptors) in cocul-
ture with brain pericytes of ECs derived from hematopoi-
etic stem cells cultivated with brain pericytes from either 
primary bovine or cell line human origin in a Transwell 
system using the Massive Analysis of cDNA Ends 
(MACE) technology. This RNA sequencing method is a 
3′-end targeted, tag-based, reduced representation tran-
scriptome profiling technique, that can reliably quantify 
all polyadenylated transcripts including those with low 
expression. By analysing the generated transcriptomic 
profiles, we can explore the molecular processes respon-
sible for the functional changes observed in ECs in cocul-
ture with brain pericytes.
To specifically focus on the pericyte-EC interaction, 
we decomposed the model in either solo- or cocultured 
ECs. Human ECs were cultivated (in a non-contact set-
up) with either human pericytes (CHP) or with bovine 
brain pericytes (CBP). In both coculture conditions, the 
ECs display BBB characteristics like restrictive tight junc-
tions, low paracellular permeability to integrity mark-
ers and functional expression of polarized uptake and 
efflux transporters [7]. We subsequently compared the 
transcriptomic profile of cocultured ECs to the tran-
scriptomic profile of solocultured ECs to delineate the 
transcriptional changes occurring in the ECs during bar-
rier establishment. Besides the transcriptomic data, BBB 
functions were assessed by drug accumulation and per-
meability studies to preliminary validate the physiological 
relevance of the used in vitro model.
Transcriptomic profiling was done using high-through-
put mRNA sequencing in combination with the digital 
gene expression profiling technique of GenXPro (Frank-
furt am Main, Germany), the MACE technology. MACE 
performs gene expression profiling by sequencing part of 
the 3′-end of mRNA transcripts. Since each sequenced 
read represents one single mRNA molecule, the MACE 
technique can accurately quantify polyadenylated tran-
scripts using a considerably lower sequencing depth than 
that of standard RNA-sequencing protocols, for which 
the number of fragments per transcript depends on the 
length of the transcript.
Our results provide a transcriptomic landscape of 
human brain-like ECs in solo- or coculture with brain 
pericytes that was used to identify interesting gene pro-
files over time, soloculture enriched transcripts, cocul-
ture enriched transcripts, etc., which might prove to be 
valuable in the further delineation of complex molecular 
processes involved in BBB formation and regulation. The 
transcriptomic profile could also be used as a source for 




The compounds lucifer yellow (LY; Mw = 457.25 g mol−1), 
rhodamine 123 (R123; Mw = 380.82  g  mol−1) and 
elacridar (GF; Mw = 563.65 g mol−1) and other materials 
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like bovine serum albumin and dimethyl sulfoxide, were 
purchased from Sigma-Aldrich (St. Quentin Fallavier, 
France).
All powdered compounds were dissolved in dimethyl 
sulfoxide or Krebs-Ringer HEPES (RH) buffer (NaCl 
150  mM, KCl 5.2  mM,  CaCl2 2.2  mM,  MgCl2 0.2  mM, 
 NaHCO3 6 mM, glucose 2.8 mM, HEPES 5 mM, sterile 
water for injection—pH: 7,4). The source and origin of all 
other materials used in this study are detailed throughout 
the methodology.
Cell culture
Soloculture of hematopoietic stem cell‑derived endothelial 
cells
The human in  vitro BBB model used in this study was 
modified from the coculture model of Cecchelli et  al. 
[7]. In brief, hematopoietic stem cell-derived ECs were 
isolated according to the method described in Cecchelli 
et  al. [7]. Vials of frozen ECs (1 × 106 cells) were rap-
idly thawed and seeded in gelatin-coated (type A from 
porcine skin) (Sigma-Aldrich) 100-mm Petri dishes 
(Costar, Corning Incorporated, NY, USA) containing 
complete medium for ECs i.e. endothelial cell medium 
(Sigma-Aldrich), supplemented with 5% fetal calf serum 
(Integro), 1% endothelial cell growth supplement (Sigma-
Aldrich) and 0.5% gentamicin (Biochrom AG, Berlin, 
Germany). Two days after defrosting, around 5.0 × 106 
cells were present and ECs were trypsinized with trypsin/
ethylenediaminetetraacetic acid (0.05%/0.02% in phos-
phate buffered saline-calcium and magnesium free (Bio-
chrom AG) and seeded on a semi-permeable Transwell 
insert (0.4  mm, 12-well system, Costar, Corning Incor-
porated) coated with Matrigel (growth factor reduced 
BD Matrigel Matrix, BD Biosciences), at a concentration 
of 16.0 × 104  cells/mL. Cells were cultivated at 37  °C in 
a humified atmosphere at 5%  CO2/95% air for a total of 
7  days and medium was changed every 2  days. All sera 
were heat-inactivated before use.
Coculture of stem cell‑derived ECs with brain pericytes
Primary bovine brain pericytes were isolated from the 
brain of freshly killed cows obtained from the slaugh-
terhouse of Douai, France according to the method 
described by Vandenhaute et al. [36]. Vials of frozen pri-
mary bovine brain pericytes (passage ≤ 3; 1.0 × 106 cells) 
were rapidly thawed and seeded in gelatin-coated 100-
mm Petri dishes containing complete medium for bovine 
pericytes (Dulbecco’s modified eagle’s medium (Gibco, 
Thermo Fisher Scientific, Villebon-sur-Yvette, France) 
supplemented with 20% fetal calf serum, 1% l-glutamine 
(Merck Chemicals, Darmstadt, Germany) and 0.5% gen-
tamicin). After 2 days, bovine pericytes were trypsinized 
and seeded, at a concentration of 1.3 × 104 cells/cm2 
on the bottom of gelatin-coated 12-well plates (Costar, 
Corning Incorporated).
The cell line of Human brain pericytes (hBPCT cell 
line) was provided by Yamaguchi University, Japan and 
derived from primary brain pericytes of a patient that 
died from a heart attack isolated and immortalized with 
retroviral vectors harboring a SV40 large T antigen gene 
according to the method described by Shimizu et al. [32]. 
Vials of frozen human brain pericyte between passage 15 
and 25 (1.0 × 106 cells) were rapidly thawed and seeded 
onto rat tail collagen (type I)-coated (BD Biosciences) 
100-mm Petri dishes containing complete medium for 
human pericytes (Dulbecco’s modified eagle’s medium 
supplemented with 10% fetal calf serum, 1% l-glutamine 
and 1% penicillin–streptomycin (Sigma-Aldrich)). The 
rat tail collagen was prepared as described by Dehouck 
et al. [12]. After 2 days, human pericytes were trypsinized 
and seeded, at a concentration of 1.3 × 104  cells/cm2 
on the bottom of rat tail collagen type I-coated 12-well 
plates.
Bovine and human brain pericytes were thawed 2 days 
before starting the coculture with ECs. Both cocultures 
were initiated by inserting the Transwell membranes 
with attached ECs into the pericyte-containing 12-well 
plates and by changing medium to endothelial cell 
medium, resulting in a non-contact BBB in vitro model, 
as no physical interaction exist between the two cell 
types. Experiments were initiated at different time points 
(i.e. 0, 24, 48 and 96 h) starting from t0, as the moment of 
coculture initiation. Cocultures were cultivated at 37  °C 
in a humified atmosphere and 5%  CO2. All sera were 
heat-inactivated before use.
Drug accumulation and permeability studies
Permeability experiments
At the different time points after putting ECs in coculture 
(i.e. 0, 24, 48, 72, 96 and 120 h), permeability experiments 
were performed to assess the EC monolayer tightness 
according to the method described in Vandenhaute et al. 
[36]. In brief, permeability was assessed by calculating the 
permeability coefficient of a fluorescent integrity marker 
(i.e. LY). To initiate experiments, Transwell inserts con-
taining confluent monolayers of ECs, were loaded with 
0.5  mL donor solution (i.e. LY (50  mM) in RH buffer) 
and were subsequently placed in a new 12-well plate 
filled with preheated RH buffer (1.5 mL). Cells were sub-
sequently incubated (37  °C, 5%  CO2) for exactly 60 min 
after which aliquots were taken from the initial donor 
solution (C0) and from the donor and receiver solutions 
at the end of the experiment (De) and (Re). The fluores-
cence intensity, hence, concentration of LY, was deter-
mined by using a fluorescence multiwell plate reader 
(Synergy H1 multiplate reader, BioTek Instruments SAS, 
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Colmar, France), using a LY filter pair of Ex (λ) 432; Em 
(λ) 538  nm. Experiments were done in triplicate (i.e. 3 
inserts), hence a total of 3 inserts with (i.e. filter + cells) 
and 3 inserts without (i.e. only filter) cells were assessed 
per condition. Simultaneously, blank wells were prepared 
using the same solution to assess background values for 
subtraction from the measured values.
The permeability coefficient (Pe, in cm  min−1) and 
clearance were calculated according to the clearance 
principle described by Siflinger-Birnboim et al. [33]. The 
clearance principle was used to obtain a concentration-
independent transport parameter.
The cleared volume (CL, in mL) was calculated by 
dividing the diffused amount of compound in the receiver 
compartment (Ar) with the concentration of compound 
in the donor compartment (Cd) (Eq. 1).
The average cumulative CL was subsequently plotted 
over time and the slope was estimated by linear regres-
sion analysis. This resulted in the permeability-surface 
area product (PS, in mL min−1). To make a correction for 
permeability across cell-free inserts, the PS products was 
calculated for both cell-free inserts (i.e. PSf, filter) and 
inserts with cells (Eq. 2).
The true or absolute Pe was then computed out of PSf 
and PSt (Eq.  3), normalized by the surface (S, in  cm2) 
(Eq. 4) [7, 16, 36].
The mass balance or recovery (in %) was determined to 
avoid deviating results due to a possible loss of the tracer 
by e.g. adsorption to plastics and non-specific binding to 
cells. The recovery was calculated by dividing the amount 
of recovered compound at the end of the experiment by 
the initial amount of tracer at t0. For Pe determination, 
a threshold recovery range was adopted between 80 and 
120%.
Rhodamine accumulation studies
Drug accumulation assays were performed to evaluate 
functional activity of P-gp in ECs. The solo- and cocul-
tured ECs were incubated for 2 h with R123 (5 mM) in 
RH buffer (supplemented with 0.1% bovine serum albu-
min) with or without GF (0.5  mM). After incubation, 
ECs were washed 3 times with ice-cold RH buffer and 
(1)Clearance(CL, in mL) = Ar
/
Cd
(2)PSt = PSf + PSe








were subsequently lysed with lysis buffer (10× RIPA lysis 
buffer, Millipore Merck, Darmstadt, Germany). Fluores-
cence detection was performed with the fluorescence 
multiwell plate reader, using an R123 filter pair of Ex (λ) 
501; Em (λ) 538 nm. Experiments were done at 37 °C in a 
humified atmosphere at 5%  CO2.
Statistical analysis
All results were expressed as means with standard devi-
ation from three or more independent experiments. 
Statistical significance was assessed by the unpaired 
Student’s t-tests with two-tailed distribution, assum-
ing equal standard deviation, or otherwise specified. A 
p-value < 0.05 was considered as significant (*p < 0.05; 
**p < 0.005, ***p < 0.001). All statistical analyses were per-
formed using GraphPad Prism 7 for Mac OS X (Graph-
Pad Software, San Diego, California, USA).
RNA sequencing: Massive Analysis of cDNA Ends (MACE) 
technology
Total RNA isolation
RNA isolation was performed at GenXPro GmbH. Cell 
lysates were stored in liquid nitrogen before RNA isola-
tion. Isolation of total RNA from ECs was performed 
using the ZR-Duet DNA/RNA MiniPrep Plus kit (Zymo 
Research, Irvine, CA, USA) according to manufacturer’s 
instructions. RNA samples were digested using DNase I 
and RNA integrity was accessed using automated capil-
lary electrophoresis (RNA pico sensitivity assay, Lab-
Chip GX II Touch HT, Perkin Elmer, Villebon-sur-Yvette, 
France).
Generation of MACE libraries and RNA sequencing
We performed genome-wide gene expression profiling of 
solo- and cocultured ECs at 0, 24, 48 and 96 h after put-
ting ECs in coculture (3 biological replicates each con-
sisting of 3 technical replicates) using the MACE method 
to identify differentially expressed genes upon pericyte 
introduction. The biological replicates were defined as 
coming from different vials of frozen ECs. These rep-
licates originate from the cord blood of 1 or 2 donors. 
For each biological replicate, we subsequently pooled 3 
inserts (i.e. technical replicates). Hence, a total of 9 rep-
licates was used.
Preparation of a next-generation sequencing library 
and subsequent RNA sequencing was performed at 
GenXPro GmbH. A number of 27 MACE libraries was 
constructed using the MACE-Seq kit v2.0 (GenXPro 
GmbH) according to the supplier’s protocol. MACE-
sequencing is a 3′-end targeted, tag-based, reduced rep-
resentation transcriptome profiling technique that can 
reliably quantify all polyadenylated transcripts.
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In general, the procedure follows a modified protocol 
described in Nold-Petry et al. [29]. In brief, samples with 
100 ng of DNase-treated RNA were used for library prep-
aration. Synthesis of cDNA was performed by reverse 
transcription using oligo (dT) primers following frag-
mentation of cDNA to an average size of 200  bp using 
sonification (Bioruptor, Diagenode, Seraing, Belgium). 
DNA was quantified using a Qubit HS dsDNA assay 
(Thermo Fisher Scientific). cDNA fragments were ligated 
to DNA adapters containing TrueQuant unique molecu-
lar identifiers included in the kit. Library amplification 
was done using polymerase chain reaction, purified by 
solid phase reversible immobilization beads (Agencourt 
AMPure XP, Beckman Coulter, Brea, CA, USA) and sub-
sequent sequencing was performed using a NextSeq plat-
form (Illumina Inc., San Diego, CA, USA).
Bioinformatic analysis of MACE data
A total of approximately 391 million MACE reads was 
obtained across all libraries (Additional file  1). Poly-
merase chain reaction-duplicates were identified using 
the TrueQuant technology and subsequently removed 
from raw data. All remaining reads were further poly 
(A)-trimmed and low-quality reads were removed, after 
which clean reads were aligned to the human reference 
genome1 using the bowtie2 mapping tool. The latter 
resulted in a gene dataset with a total of 25,684 different 
genes. The gene count data was normalized to account 
for differences in library size and RNA composition bias 
by calculating the median of gene expression ratios using 
DESeq  2 R/Bioconductor package [27]. This resulted in 
a p-value and log2-fold change (log2FC) for every gene 
for 2 conditions. False discovery rate was estimated to 
account for multiple testing. During bioinformatic analy-
sis, differentially expressed transcripts were identified 
using a combination of thresholds for p-value < 0.05 and 
|log2FC| > 1, as performed by Munji et  al. [28]. During 
experimental design, these thresholds were considered 
to be correct to analyse even the most subtle changes 
in gene expression during the time course of the experi-
ment, due to the characteristics of the experimental 
setup, biological questions and analysis. Additionally, 
the accurate quantification of mRNA transcripts using 
MACE sequencing allowed identification of differentially 
expressed genes using the combination of p-value and 
log2FC.
Differentially expressed genes were further categorized 
in solo- and coculture enriched genes. The ratio between 
the normalized expression of a specific gene in solocul-
tured ECs and the normalized expression of the same 
gene in cocultured ECs resulted in soloculture enriched 
genes if the ratio exceeded 2, or otherwise specified. The 
ratio between the normalized expression of a specific 
gene in cocultured ECs and the normalized expression 
of the same gene in solocultured ECs resulted in cocul-
tured enriched genes if the ratio exceeded 2. To obtain 
enriched genes, some thresholds were made to ensure to 
have taken into account only valuable genes (i.e. raw data 
count of the enriched condition > 20, exclusion of pseu-
dogenes and non-coding genes).
Genes were further assigned to biological pathways 
to analyse signaling and metabolic pathways by using 
the Gene Ontology (GO) enrichment tool (GenXPro 
GmbH), the Ingenuity Pathway Analysis and the KOBAS 
web server. These functional enrichment tools were used 
to evaluate the functional properties of gene sets, thereby 
resulting in over- or underrepresented GO terms for a set 
of genes that were up- or downregulated in our compari-
sons. The used software consists of databases that classi-
fies genes according to their roles in the cell, allowing to 
identify ‘pericyte or coculture enriched’ signaling path-
ways [18]. Statistical analysis of the GO enrichment anal-
ysis consisted of the Fisher’s exact test among transcripts 
that were differentially expressed at a p-value < 0.05.
Availability of data
The generated transcriptomic data for this study, includ-
ing both the raw data and the counts matrix, has been 
deposited in the Gene Expression Omnibus (GEO) data-
base with the ascension ID of GSE144474. The data will 
also be made available at the BBBHub (http://bbbhu 
b.unibe .ch) upon launch.
Results
Influence of brain pericytes on functional barrier 
properties: Barrier tightness and efflux transporter 
functionality
The effect of brain pericytes on the barrier tightness and 
efflux transporter functionality in ECs was assessed by 
permeability studies to determine the tightness of the 
endothelial monolayer and by drug accumulation stud-
ies to assess functionality of ATP-binding cassette (ABC) 
efflux transporters e.g. P-glycoprotein (P-gp/ABCB1/
MDR1) and breast cancer resistance protein (BCRP/
ABCG2).
The ECs monolayer’s tightness was investigated by 
studying the Pe of the commonly used hydrophilic 
integrity marker, LY, across the endothelial cell mon-
olayer. Both pericyte co-cultures (i.e. CBP and CHP) 
significantly decreased the permeability to LY over time 
(Fig.  1). The Pe to LY for solocultured ECs remained 
higher and relatively stable throughout the whole-time 
range, with an average over time of 1.36 ± 0.27 × 10−3 1 hg38, http://genom e.ucsc.edu/cgi-bin/hgTab les.
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cm.min−1. The Pe to LY for the CBP and CHP 
decreased, when compared with the Pe of the solocul-
tured ECs, and this by 37% (CBP) and 14% (CHP) after 
48  h, by 31% (CBP) and 46% (CHP) after 96  h and by 
32% (CBP) and 45% (CHP) after 120  h. The Pe to LY 
is 1.10 ± 0.17 × 10−3 cm  min−1 and 1.72 ± 0.07 × 10−3 
cm  min−1 after 24  h and 0.82 ± 0.04 × 10−3  cm  min−1 
and 0.67 ± 0.04 × 10−3  cm  min−1 after 120  h for the 
CBP and CHP respectively. These results demonstrate 
a common reduction of endothelial permeability over 
time for ECs cocultured with brain pericytes, which 
confirms the involvement of brain pericytes in regulat-
ing and/or inducing important BBB features. The latter 
has been shown by several other studies [8, 10, 11, 22].
The functionality of the P-gp and BCRP efflux pumps 
was evaluated by a drug accumulation assay with P-gp 
and BCRP substrate R123. Cells were incubated with 
R123 in presence and absence of a P-gp and BCRP 
inhibitor, GF. Our results evidence the presence of func-
tional efflux pumps in both solo- and cocultured ECs as 
demonstrated by an increased intracellular accumula-
tion of R123 in presence of inhibitor (i.e. 43% and 42% 
for the CBP and CHP, respectively), compared to the 
baseline condition (i.e. depicting R123 accumulation in 
absence of GF) (Fig. 2a). Although not significantly dif-
ferent from the cocultured ECs, the difference between 
the intracellular accumulation of R123 in absence and 
in presence of inhibitor seems to be somewhat higher 
in the solocultured ECs. This is also reflected by the 
transcriptomic data (Fig.  2b) that shows an overall 
downregulation of P-GP and a decreasing expression of 
BCRP over time in cocultured ECs compared to solo-
cultured ECs. Several studies show a pericyte-enhanced 
P-gp function or a higher P-GP expression in rodent 
brain vasculature compared to peripheral vasculature 
[10, 11, 15]. The latter is not reflected by our data.




























Fig. 1 Endothelial permeability coefficient  (Pe) to LY (50 mM) over 
time of the endothelial cell monolayer in soloculture (solo, blue), 
in coculture with bovine pericytes (CBP, red) and in coculture 
with human pericytes (CHP, green). Data is shown as a mean 
(N = 3) ± standard deviation, statistics were done by a two-tailed 
unpaired t-test and a significantly different  Pe to LY in CBP or CHP 
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Fig. 2 a Efflux pump activity measured by the intracellular accumulation of rhodamine 123 (R123) in absence (red) or presence (green, lines) of 
the inhibitor, elacridar (GF) in solocultured endothelial cells (Solo), or in cocultured endothelial cells with bovine pericytes (CBP) and cocultured 
endothelial cells with human pericytes (CHP). Data is shown as the mean amount intracellular accumulated R123 with standard deviation (in 
RFU) (N = 3). b Expression profile of ABC efflux transporters P-gp and BCRP in endothelial cells cocultured with human pericytes (CHP, green) or 
bovine pericytes (CBP, red). Expression is depicted as relative expression (in %) compared to the expression in solocultured endothelial cells at the 
corresponding time points
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Influence of brain pericytes on the transcriptomic profile 
of brain‑like endothelial cells
To identify the influence of brain pericytes on the tran-
scriptomic expression profile of ECs, we utilized the 
MACE RNA sequencing technique. Therefore, we com-
pared the gene expression of solocultured ECs to the 
gene expression of cocultured ECs.
Influence of pericytes on the global gene expression profile 
of brain‑like endothelial cells
The MACE gene expression profiling of ECs in solocul-
ture or in coculture with brain pericytes identified sev-
eral clusters of gene responses: (i) up- or downregulated 
genes in cocultured ECs compared to solocultured ECs; 
(ii) up- or downregulated genes in ECs in the CBP com-
pared to solocultured ECs; (iii) up- or downregulated 
genes in ECs in the CHP compared to solocultured ECs; 
and (iv) up- or downregulated genes at specific time 
points in cocultured ECs compared to solocultured ECs 
(Table 1).
Figure 3a shows the number of differentially expressed 
genes (|log2FC| > 1) for the comparison between cocul-
tured ECs and solocultured ECs over time. This graph 
indicates an increase in differentially expressed genes 
over time for both cocultures, as well as it shows a higher 
number of differentially expressed genes in ECs from 
CHP compared with CBP. Figure 3b shows the number of 
differentially expressed genes (|log2FC| > 2) for the com-
parison between cocultured ECs and solocultured ECs 
over time. This graph shows (i) a higher number of differ-
entially expressed genes in the comparison of soloculture 
vs. CHP, compared to the comparison of soloculture vs. 
CBP; (ii) an increased amount of differentially expressed 
genes over time for both the comparison of soloculture 
vs. coculture in general; and (iii) a clearly higher number 
of upregulated differentially expressed genes compared 
to downregulated differentially expressed genes for the 
comparison soloculture vs. CHP, which is not reflected in 
the comparison soloculture vs. CBP.
These results suggest that coculturing with human 
pericytes affects the gene expression profile more rap-
idly and slightly more than coculturing with bovine peri-
cytes. However, the influence of pericytes is minor in 
both cases, as no more than 5% of the total number of 
genes is altered significantly upon coculturing. However, 
numerous genes are significantly affected (p-value < 0.05 
and |log2FC| > 1) or |log2FC| > 2), but the change in 
expression levels is small, indicating a low responsiveness 
towards factors originating from pericytes.
Enriched gene expression
Differentially expressed genes were categorized in solo-
culture enriched and coculture enriched genes. Genes 
were identified as soloculture enriched when expressed 
at high levels in soloculture conditions and poorly or 
not expressed in coculture conditions. The opposite was 
true for coculture enriched genes. Our results indicate 
an increased number of soloculture enriched genes over 
time (ratio ≥ 3) (Fig. 4a), as well as an increased number 
of coculture enriched genes over time (ratio ≥ 3) (Fig. 4b) 
(i.e. for both the CHP and the CBP). Interestingly, the 
identified number of soloculture enriched genes in the 
comparison with the CHP shows to be threefold higher 
than for any other comparison.
A list of the ten of most enriched soloculture and cocul-
ture genes, for every comparison at each time point, was 
generated (Tables 2, 3). Within this list, genes that were 
identified to be enriched in both comparisons (i.e. solo-
culture vs. CHP and soloculture vs. CBP) are depicted in 
bold. These top regulated genes (Tables 2, 3) are partially 
validated by Ingenuity Pathway Analysis as several of the 
coculture enriched genes are found back in the list of top 
Table 1 Summary of different clusters of gene responses
The percentage of differentially expressed transcripts (p < 0.05) is shown in the second column for every condition and is depicted as a percentage of the total number 
(i.e. 25 684) of mapped genes. Column 3 and 4 show differentially expressed transcripts in cocultured vs. solocultured endothelial cells characterized by a |log2FC| > 1. 





Up‑regulated Total regulated Down‑
regulated
Up‑regulated Total regulated
% (p‑value < 0.05; |log2FC| | > 1) (p‑value < 0.05; |log2FC| > 2)
CBP vs. Solo (h)
 24 5.8 207 114 321 (1.2%) 49 26 75 (0.3%)
 48 14.6 302 343 645 (2.5%) 70 109 179 (0.7%)
 96 15.1 513 253 766 (3.0%) 148 72 210 (0.8%)
CHP vs. SOLO (h)
 24 20.4 414 534 948 (3.7%) 41 199 240 (0.9%)
 48 16.1 297 561 858 (3.3%) 54 188 242 (0.9%)
 96 18.7 644 591 1235 (4.8%) 114 260 374 (1.5%)
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a b
Fig. 3 Number of differentially expressed transcripts for the cocultured vs. solocultured endothelial cells at different time points i.e. 24, 48 and 
96 h. Coculture conditions were depicted as CBP for coculture with bovine pericytes and CHP for cocultures with human pericytes. Differentially 
expressed transcripts are characterized by (a) a |log2FC | > 1; and b a |log2FC| > 1 and categorized in up- (green)- and down- (red) regulated 
transcripts in cocultured endothelial cells compared with their expression in solocultured endothelial cells. The total number of transcripts in line 






































































































































Fig. 4 a Number of soloculture enriched genes (ratio ≥ 3) for solo- vs. coculture comparisons at different time points i.e. 24, 48 and 96 h. b Number 
of coculture enriched genes (ratio ≥ 3) for solo- vs. coculture comparisons. Coculture with bovine pericytes (CBP) depicted in red and coculture with 
human pericytes (CHP) depicted in green. The comparisons at 24 h were performed with a soloculture at 0 h, as no analysis was performed for a 
soloculture at 24 h
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regulated genes from the Ingenuity Pathway Analysis 
(data not shown). 
As overlapping genes between the two cocultures can 
be a first type of validation, a full comparison of overlap-
ping genes in both comparisons was made. For this, we 
assessed the number of overlapping enriched genes in 
both comparisons (i.e. solo- vs. CHP and solo- vs. CBP). 
We only included those enriched genes that were char-
acterized by a ratio ≥ 2 (Table 4 and 5). This assessment 
indicated that both soloculture and coculture overlap-
ping enriched genes increase in number over time. 
Gene expression profile of specific genes
We also assessed the gene expression profile over time 
for some specific gene groups related to the BBB i.e. vas-
cular permeability genes, junction associated genes, tight 
junction and tight junction associated genes, ABC trans-
porter genes and endothelial marker genes (Fig.  5), as 
Table 2 Top 10 of  the  most enriched soloculture genes at  24  h (top), 48  h (middle) and  96  h (bottom) for  (A) 
the comparison of soloculture (Solo) vs. coculture with human pericytes (CHP); and for (B) the comparison of soloculture 
vs. coculture with bovine pericytes (CBP)
a Gene Gene description Ratio Solo/CHP p-value Log2FC
ID2 inhibitor of DNA binding 2, dominant
negative helix-loop-helix protein
7.2 7.26E-10 2.8
ESM1 endothelial cell-specific molecule 1 4.4 2.07E-19 2.1
CCL2 chemokine (C-C motif) ligand 2 4.1 2.68E-09 2.0
HTR2B killer cell lectin-like receptor subfamily
G, member 1
3.8 2.76E-08 1.9
ANXA3 annexin A 3.8 4.65E-07 1.9
BMPER BMP binding endothelial regulator 3.7 7.95E-08 1.9
BAMBI BMP and activin membrane-bound 
inhibitor
3.4 1.20E-06 1.7
EGR1 early growth response 1 3.3 4.26E-12 1.7
IGFBP7 insulin-like growth factor binding protein 
7
3.1 2.32E-08 1.6
CYR61 cysteine-rich, angiogenic inducer, 61 3.1 4.68E-04 1.6
CRHBP corticotropin releasing hormone binding 
protein
31.8 4.38E-16 5.0
BMPER BMP binding endothelial regulator 9.7 4.26E-16 3.3
FABP4 fatty acid binding protein 4, adipocyte 7.5 3.23E-25 3.0
GJA4 gap junction protein, alpha 4, 37kDa 7.2 7.67E-09 2.9
CLEC3B C-type lectin domain family 3, member B 6.3 2.62E-23 2.7
ID2 inhibitor of DNA binding 2, dominant
negative helix-loop-helix protein
5.3 1.43E-08 2.4
EPHX4 epoxide hydrolase 4 5.2 4.37E-07 2.4
ABCB1 ATP-binding cassette, sub-family B
(MDR/TAP), member 1
5.2 5.38E-15 2.4
GUCY1A3 guanylate cyclase 1, soluble, alpha 3 5.0 3.08E-09 2.3
SESN3 sestrin 3 4.3 5.69E-08 2.1
BMPER BMP binding endothelial regulator 88.7 1.32E-28 6.2
CRHBP corticotropin releasing hormone binding 
protein
24.3 1.48E-11 4.4
EGR3 early growth response 3 22.1 8.70E-21 3.7
FABP4 fatty acid binding protein 4, adipocyte 18.8 2.81E-33 3.2
ACP5 acid phosphatase 5, tartrate resistant 10.8 3.77E-14 2.7
GJA5 gap junction protein, alpha 5, 40kDa 10.6 2.74E-15 2.6
NR4A1 nuclear receptor subfamily 4, group A, 
member 1
9.2 1.55E-08 2.6
ID2 inhibitor of DNA binding 2, dominant
negative helix-loop-helix protein
8.9 2.00E-13 2.6
EPHB1 EPH receptor B1 8.2 1.67E-08 2.6
GJA4 gap junction protein, alpha 4, 37kDa 8.0 2.63E-11 2.6
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well as the gene expression profile of solute carrier (SLC) 
transporter genes (Fig. 6). The latter shows a major clus-
tering in the expression of these genes of both cocultures 
at 48 h and 96 h in one cluster and soloculture at 0, 48 
and 96 h together with both cocultures at 24 h in another 
cluster. Addition of pericytes is shown to lead to different 
responses for the different conditions (Figs. 5, 6). Most of 
these responses were already identified by other studies 
[6, 10, 11].
Interestingly, among the gene expression profiles of 
known vascular permeability genes, the plasmalemma 
vesicle-associated protein (PLVAP) expression is 
highly increased at 24 h for both cocultures, however it 
decreases drastically from 24 to 96 h. The expression of 
the intercellular adhesion molecule 1 (ICAM1) and angi-
opoietin 1 (ANGPT1) is decreased in both cocultures 
compared to the soloculture (Fig. 5). The expression pro-
file of several junction associated genes is altered upon 
the presence of brain pericytes compared to its expres-
sion in ECs alone (Fig. 5). And the relative gene expres-
sion pattern of several tight junction and tight junction 
associated genes suggests that important tight junction 
Table 2 (continued)
b      Gene Gene description
Ratio 
Solo/CBP p-value Log2FC
DUSP8 dual specificity phosphatase 8 5.3 1.91E-08 2.4
CREB5 cAMP responsive element binding protein 
5
3.3 4.49E-08 1.7
MIF macrophage migration inhibitory factor
(glycosylation-inhibiting factor)
2.6 0.16 1.4
EGR1 early growth response 1 2.4 2.37E-06 1.3
IL4I1 interleukin 4 induced 1 2.4 1.04E-08 1.1
IL32 interleukin 32 2.2 7.54E-08 1.1
RELB v-rel avian reticuloendotheliosis viral
oncogene homolog B
2.2 1.70E-03 1.1
TGFB2 transforming growth factor, beta 2 2.1 2.63E-05 1.1
ARL4C ADP-ribosylation factor-like 4C 2.1 1.39E-04 1.0
VCAM1 vascular cell adhesion molecule 1 2.1 1.11E-04 1.0
CYP1A1 cytochrome P450, family 1, subfamily A, 
polypeptide 1
34.6 4.00E-13 5.1
CRHBP corticotropin releasing hormone binding 
protein
8.8 5.42E-12 3.1
BMPER BMP binding endothelial regulator 8.3 2.18E-15 3.1
HTR2B killer cell lectin-like receptor subfamily
G, member 1
5.0 4.25E-10 2.3
GUCY1A3 guanylate cyclase 1, soluble, alpha 3 4.7 4.41E-09 2.2
GJA4 gap junction protein, alpha 4, 37kDa 4.4 5.28E-06 2.1
EPHX4 epoxide hydrolase 4 4.1 2.76E-06 2.0
FABP4 fatty acid binding protein 4, adipocyte 3.9 9.46E-14 2.0
SESN3 sestrin 3 3.5 5.85E-07 1.8
ID2 inhibitor of DNA binding 2, dominant
negative helix-loop-helix protein
3.4 4.47E-06 1.8
EGR3 early growth response 3 72.9 1.46E-24 6.5
CYP1A1 cytochrome P450, family 1, subfamily A, 
polypeptide 1
21.6 1.67E-22 4.6
BMPER BMP binding endothelial regulator 13 1.11E-22 4.5
FABP4 fatty acid binding protein 4, adipocyte 8.9 1.78E-46 4.2
NR4A1 nuclear receptor subfamily 4, group A, 
member 1
6.5 1.58E-24 3.4
GJA5 gap junction protein, alpha 5, 40kDa 6.2 5.02E-16 3.4
GJA4 gap junction protein, alpha 4, 37kDa 6.1 9.15E-16 3.2
CRHBP corticotropin releasing hormone binding 
protein
6.1 2.81E-12 3.2
NOS1 nitric oxide synthase 1 (neuronal) 6.0 4.27E-09 3.0
ATP2A3 ATPase, Ca++ transporting, ubiquitous 5.9 8.43E-10 3.0
Shading color highlights soloculture enriched genes that are identified to be in the top 10 of two (light grey) or all time points (dark grey)
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and tight junction accessory genes are expressed i.e. 
claudin 3 and 5 (CLDN3, CLDN5), occludin (OCLN), 
tight junction protein 1 and 2 (TJP1, TJP2) etc. How-
ever, their expression is not necessarily increased upon 
presence of brain pericytes (Fig.  5). The expression pat-
tern of endothelial cell marker genes CD34, C-type 
lectin domain family 14, member A (CLEC14A), von 
Willebrand factor (VWF) and nitric oxide synthase 
(NOS3) at 24 to 96  h shows an increased expression of 
VWF, a decreased expression of CLEC14A and NOS3 
and a steady state for CD34, at least for the coculture 
with bovine pericytes (Fig.  5). These genes are known 
endothelial marker genes and are known to be expressed 
in different type of ECs [6].
Influence of pericytes on signaling pathways in brain‑like 
endothelial cells
The GO enrichment analysis identified a number of sig-
nificantly different gene clusters for soloculture condi-
tions vs. coculture conditions. The number of significant 
gene clusters per assigned ontology, i.e. molecular func-
tion, cellular component and biological process were 
identified.
Table 3 Top 10 of the most enriched coculture genes at 24 h (top), 48 h (middle) and 96 h (bottom) for (A) the comparison 
of  soloculture (Solo) vs. coculture with  human pericytes (CHP); and  for  (B) the  comparison of  soloculture vs. coculture 
with bovine pericytes (CBP)
A Gene Gene description Ratio CHP/Solo p-value Log2FC 
HIST1H4C histone cluster 1, H4c 43.5 7.45E-13 -5.4
EXOC3L2 exocyst complex component 3-like 2 26.1 1.04E-24 -4.7
ACKR1 atypical chemokine receptor 1 (Duffy 
blood group) 
17.1 6.82E-32 -4.1
INMT indolethylamine N-methyltransferase 11.1 1.63E-13 -3.5
A2M alpha-2-macroglobulin 7.7 1.15E-16 -3.0
SIRPB2 signal-regulatory protein beta 2 7.5 3.62E-09 -2.9
ZNF366 zinc finger protein 366 5.9 1.29E-07 -2.6
CCL23 chemokine (C-C motif) ligand 23 5.2 1.63E-11 -2.4
PRR11 proline rich 11 5.0 1.06E-08 -2.3
MMP1 matrix metallopeptidase 1 (interstitial 
collagenase) 
4.9 3.91E-20 -2.3
STC1 stanniocalcin 1 57.9 1.37E-23 -5.6
HIST1H4C histone cluster 1, H4c 25.5 9.27E-11 -4.5
ACKR1 atypical chemokine receptor 1 (Duffy 
blood group) 
21.0 6.67E-28 -4.4
NPR3 natriuretic peptide receptor 3 12.7 3.70E-19 -3.7
INHBB inhibin, beta B 9.9 1.24E-16 -3.3
SLC2A3 solute carrier family 2 (facilitated 
glucose transporter), member 3 
7.5 5.95E-25 -2.9
EXOC3L2 exocyst complex component 3-like 2 7.0 4.31E-13 -2.8
SOCS3 suppressor of cytokine signaling 3 6.9 8.95E-46 -2.8
CADM3 cell adhesion molecule 3 5.8 1.10E-11 -2.5
ODF3B outer dense fiber of sperm tails 3B 5.6 2.60E-14 -2.5
HISTAH4C histone cluster 1, H4c 43.1 1.25E-17 -5.4
NPR3 natriuretic peptide receptor 3 38.2 1.37E-39 -5.3
STC1 stanniocalcin 1 33.8 1.27E-27 -5.1
ACKR1 atypical chemokine receptor 1 (Duffy 
blood group) 
23.2 2.59E-28 -4.5
IGFBP5 insulin-like growth factor binding protein 
5 
14.1 2.92E-14 -3.8
SLC2A3 solute carrier family 2 (facilitated 
glucose transporter), member 3 
7.9 3.69E-28 -2.3
ODF3B outer dense fiber of sperm tails 3B 7.6 5.23E-20 -2.9
ZC3H6 zinc finger CCCH-type containing 6 6.2 2.58E-28 -2.6
INHBA inhibin, beta A 6.2 7.01E-38 -2.6
IGF2 insulin-like growth factor 2 
(somatomedin A) 
5.7 2.94E-38 -2.5
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Molecular function describes and represents activi-
ties rather than entities that occur at the molecular level, 
such as RNA binding and cytokine binding. A cellu-
lar component consists of a component of a cell, that is 
inherently part of a larger object, such as the ribosome 
and endoplasmic reticulum. The last ontology parameter 
represents a biological process and defines a series of 
events by one or more groups of molecular functions, 
such as the Wnt signaling pathway and protein folding.
Our results indicate very similar numbers of signifi-
cant pathways or gene clusters over time for each of the 
comparisons.
Table 3 (continued)
B Gene Gene description Ratio CBP/Solo p-value Log2FC 
INMT indolethylamine N-methyltransferase 9.2 6.93E-11 -3.2
NPW neuropeptide W 4.9 1.33E-15 -2.3
ACKR1 atypical chemokine receptor 1 (Duffy 
blood group) 
4.7 2.18E-09 -2.2
IGFBP1 insulin-like growth factor binding protein 
1 
3.7 3.75E-08 -1.9
CCL23 chemokine (C-C motif) ligand 23 3.7 5.92E-07 -1.9
IL1RL1 interleukin 1 receptor-like 1 3.0 3.02E-42 -1.6
LIPG lipase, endothelial 2.7 2.19E-05 -1.4
TMEM100 transmembrane protein 100 2.5 1.81E-03 -1.3
ANGPTL4 angiopoietin-like 4 2.5 5.92E-15 -1.3
SELP selectin P (granule membrane protein 
140kDa, antigen CD62) 
2.5 1.86E-13 -1.3
ACKR1 atypical chemokine receptor 1 (Duffy 
blood group) 
12.6 4.88E-18 -3.7
INMT indolethylamine N-methyltransferase 12.3 3.63E-22 -3.6
CADM3 cell adhesion molecule 3 7.3 2.08E-15 -2.9
PTP4A3 protein tyrosine phosphatase type IVA, 
member 3 
5.3 2.29E-13 -2.4
NOTCH3 notch 3 4.9 1.02E-14 -2.3
SOCS3 suppressor of cytokine signaling 3 4.9 4.70E-31 -2.3
PIM1 Pim-1 proto-oncogene, serine/threonine 
kinase 
4.9 1.56E-12 -2.3
SLC2A3 solute carrier family 2 (facilitated 
glucose transporter), member 3 
4.7 5.79E-14 -2.2
ANGPTL4 angiopoietin-like 4 4.6 1.38E-35 -2.2
CDH15 cadherin 15, type 1, M-cadherin 
(myotubule) 
4.5 4.76E-07 -2.2
MCHR1 melanin-concentrating hormone receptor 
1 
53.0 1.70E-19 -5.7
ACKR1 atypical chemokine receptor 1 (Duffy 
blood group) 
29.1 2.85E-30 -4.9
NPR3 natriuretic peptide receptor 3 22.9 3.59E-24 -4.5
CADM3 cell adhesion molecule 3 8.6 1.21E-15 -3.1
INMT indolethylamine N-methyltransferase 7.9 4.20E-16 -3.0
SLC2A3 solute carrier family 2 (facilitated 
glucose transporter), member 3 
7.8 1.06E-25 -2.3
SOCS3 suppressor of cytokine signaling 3 6.2 1.38E-42 -2.6
IGFBP1 insulin-like growth factor binding protein 
1 
5.7 1.58E-13 -2.5
FBLN2 fibulin 2 5.5 3.46E-32 -2.5
AK4 adenylate kinase 4 5.2 8.13E-15 -2.4
Shading colour highlights coculture enriched genes that are identified to be in the top 10 of two (light grey) or all time points (dark grey)Shading colour highlights 
coculture enriched genes that are identified to be in the top 10 of two (light grey) or all time points (dark grey)
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Table 4 Overlapping soloculture enriched genes (ratio ≥ 2) at  24  h (top), 48  h (middle) and  96  h (bottom) identified 
in both comparisons i.e. soloculture vs. coculture with human pericytes (CHP) and soloculture vs. coculture with bovine 
pericytes (CBP)
Gene Gene description Gene Gene description 
24 hours 
ARL4C ADP-ribosylation factor-like 
4C 
IL32 interleukin 32 
CREB5 cAMP responsive element 
binding protein 5 
IL4I1 interleukin 4 induced 1 
 
DCAF12L1 DDB1 and CUL4 associated 
factor 12-like 1 
PLA2G4C phospholipase A2, group IVC 
(cytosolic, calcium-
independent) 
DUSP8 dual specificity phosphatase 
8 
TGFB2 transforming growth factor, 
beta 2 
EGR1 early growth response 1 VCAM1 vascular cell adhesion 
molecule 1 
48 hours 
ABCB1 ATP-binding cassette, sub-
family B (MDR/TAP), 
member 1 





HIST1H2AC histone cluster 1, H2ac 
 
BAMBI BMP and activin membrane-
bound inhibitor 
HIST1H2BD histone cluster 1, H2bd 
 
BMPER BMP binding endothelial 
regulator 
HTR2B killer cell lectin-like receptor 
subfamily G, member 1 
CCL14 chemokine (C-C motif) 
ligand 14 
ID2 inhibitor of DNA binding 2, 
dominant negative helix-
loop-helix protein 
CDH11 cadherin 11, type 2, OB-
cadherin (osteoblast) 
PDGFD platelet derived growth 
factor D 
CNBD2 cyclic nucleotide binding 
domain containing 2 
PLAT plasminogen activator, tissue 
CRHBP corticotropin releasing 
hormone binding protein 
PTPRD protein tyrosine phosphatase, 
receptor type, D 
CRISPLD1 cysteine-rich secretory 
protein LCCL domain 
containing 1 
SESN3 sestrin 3 
EPHX4 epoxide hydrolase 4 SLC25A4 solute carrier family 25 
(mitochondrial carrier; 
adenine nucleotide 
translocator), member 4 
FABP4 fatty acid binding protein 4, 
adipocyte 
SLC40A1 solute carrier family 40 
(iron-regulated transporter), 
member 1 
FABP5 fatty acid binding protein 5, 
adipocyte 
STEAP1 six transmembrane epithelial 
antigen of the prostate 1 
FLRT2 fibronectin leucine rich 
transmembrane protein 2 
SYNM synemin, intermediate 
filament protein 
GDF3 growth differentiation factor 
3 
TM4SF18 transmembrane 4 L six 
family member 18 
GJA4 gap junction protein, alpha 
4, 37kDa 
TRIM16 tripartite motif containing 16 
GJA5 gap junction protein, alpha 
5, 40kDa 
TSPAN7 tetraspanin 7 
GUCY1A3 guanylate cyclase 1, soluble, 
alpha 3 
ZNF326 zinc finger protein 326 
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Tables 6 and 7 list the top solo- and coculture enriched 
pathways per comparison and per time point identified 
by the GO enrichment tool. Pathways were enriched if 
p < 0.05 and when the number of significant upregulated 




ACP5 acid phosphatase 5, tartrate 
resistant 
IFIT3 interferon-induced protein 
with tetratricopeptide repeats 
3 
ACSM3 acyl-CoA synthetase 
medium-chain family 
member 3 
IL32 interleukin 32 
AMDHD2 amidohydrolase domain 
containing 2 
IL4I1 interleukin 4 induced 1 
AMH anti-Mullerian hormone KIFC1 kinesin family member C1 
AP4S1 adaptor-related protein 
complex 4, sigma 1 subunit 
KLRK1 killer cell lectin-like receptor 
subfamily K, member 1 
ARL4C ADP-ribosylation factor-like 
4C 




ATAD3B ATPase family, AAA domain 
containing 3B 
MMP10 matrix metallopeptidase 10 
(stromelysin 2) 
ATOH8 atonal homolog 8 
(Drosophila) 
MT1E metallothionein 1E 
ATP2A3 ATPase, Ca++ transporting, 
ubiquitous 
MT1X metallothionein 1X 
BMPER BMP binding endothelial 
regulator 
MYBL2 v-myb avian myeloblastosis 
viral oncogene homolog-like 
2 
CDH11 cadherin 11, type 2, OB-
cadherin (osteoblast) 
NOS1 nitric oxide synthase 1 
(neuronal) 
CENPM centromere protein M NR4A1 nuclear receptor subfamily 4, 
group A, member 1 
oxidase assembly factor
CREB5 cAMP responsive element 
binding protein 5
PLA2G4C phospholipase A2, group IVC 
(cytosolic, calcium-
independent)
CRHBP corticotropin releasing 
hormone binding protein
POSTN periostin, osteoblast specific
factor
CYP1A1 cytochrome P450, family 1, 
subfamily A, polypeptide 1
PRKCD protein kinase C, delta
DCBLD2 discoidin, CUB and LCCL 
domain containing 2
RAMP2 receptor (G protein-coupled) 
activity modifying protein 2
DDX39A DEAD (Asp-Glu-Ala-Asp) 
box polypeptide 39A
RASGRP3 RAS guanyl releasing protein 
3 (calcium and DAG-
regulated)
EGR1 early growth response 1 SEMA3G sema domain, 
immunoglobulin domain (Ig), 
short basic domain, secreted, 
(semaphorin) 3G
EGR3 early growth response 3 SESN3 sestrin 3
EHD3 EH-domain containing 3 SLC25A34 solute carrier family 25, 
member 34
EPHB1 EPH receptor B1 SPAG5 sperm associated antigen 5
EPS8L1 EPS8-like 1 STMN1 Stathmin 1
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Table 8, 9, 10 and 11 list several top regulated signifi-
cant pathways or gene clusters per comparison and per 
time point (i.e. 24 and 96 h) that were identified by using 
the KOBAS software, thereby focusing on databases like 
Panther, KEGG and Reactome [37].
Besides a general analysis of the number of differentially 
expressed pathways, analysis was performed for specific 
gene clusters or pathways that are known to relate to BBB 
induction, maturation or maintenance (Fig.  7). Other 
gene clusters like those for transferrin transport, organic 
acid transport, anion transport and L-amino acid trans-
port did not show any significant difference between the 
solo- and coculture (data not shown). Our results show 
a general high variability in differential expression over 
time, indicating the importance of time.
An interesting cluster of genes is the one related to 
the regulation of membrane permeability. The latter is 
significantly enriched in the soloculture compared to 
CHP at 24 h, after which significance is lost (at 48 h and 
96 h), although the soloculture shows a general upregu-
lation. For the comparison between the soloculture and 
CBP, this cluster of genes related to the regulation of 
membrane permeability, is the only cluster of genes in 
this graph that is enriched for the soloculture. This indi-
cates that the genes that significantly differ are upregu-
lated in the soloculture. The cluster of genes related 
Table 4 (continued)
FABP5 fatty acid binding protein 5, 
adipocyte
SULT1E1 sulfotransferase family 1E, 
estrogen-preferring, member 
1
FAM13B family with sequence 
similarity 13, member B
SYNM synemin, intermediate 
filament protein
FEN1 flap structure-specific 
endonuclease 1
TACC3 transforming, acidic coiled-
coil containing protein 3
FLRT2 fibronectin leucine rich 
transmembrane protein 2
TCTA T-cell leukemia translocation 
altered
GDF3 growth differentiation factor 
3
TEFM transcription elongation 
factor, mitochondrial
GINS2 GINS complex subunit 2 
(Psf2 homolog)
TK1 thymidine kinase 1, soluble
GJA4 gap junction protein, alpha 
4, 37kDa
TNFRSF4 tumor necrosis factor 
receptor superfamily, 
member 4
GJA5 gap junction protein, alpha 
5, 40kDa
TP53I3 tumor protein p53 inducible 
protein 3
GUCY1A3 guanylate cyclase 1, soluble, 
alpha 3
TRBC2 T cell receptor beta constant 
2
HIST1H2AC histone cluster 1, H2ac TRIM16 tripartite motif containing 16
HIST1H2BD histone cluster 1, H2bd TRIM16L tripartite motif containing 
16-like
HIST1H4J histone cluster 1, H4j TROAP trophinin associated protein
HIST1H4K histone cluster 1, H4k TUBA1A tubulin, alpha 1a
HTR2B killer cell lectin-like receptor 
subfamily G, member 1
WNT9A wingless-type MMTV 
integration site family, 
member 9A
ID1 inhibitor of DNA binding 1, 
dominant negative helix-
loop-helix protein
ZFP36 ZFP36 ring finger protein
ID2 inhibitor of DNA binding 2, 
dominant negative helix-
loop-helix protein
ZWINT ZW10 interacting 
kinetochore protein
IFIT2 interferon-induced protein 
with tetratricopeptide repeats 
2
FABP4 fatty acid binding protein 4, 
adipocyte
STMN3 stathmin-like 3
Shading colour highlights soloculture enriched genes that are identified to be overlapping in two (light grey) or all time points (dark grey)
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Table 5 Overlapping coculture enriched genes (ratio ≥ 2) at  24  h (top), 48  h (middle) and  96  h (bottom) identified 
in both comparisons i.e. soloculture vs. coculture with human pericytes (CHP) and soloculture vs. coculture with bovine 
pericytes (CBP)
Gene Gene description Gene Gene description 
24 hours 
ACKR1 atypical chemokine receptor 
1 (Duffy blood group) 
MMP1 matrix metallopeptidase 1 
(interstitial collagenase) 
CCL23 chemokine (C-C motif) 
ligand 23 
MSMP microseminoprotein, prostate 
associated 
ETV4 ets variant 4 NPW neuropeptide W 
IL1RL1 interleukin 1 receptor-like 1 SELP selectin P (granule membrane 




SLCO2A1 solute carrier organic anion 
transporter family, member 
2A1 
LIPG lipase, endothelial SOCS3 suppressor of cytokine 
signaling 3 
MGP matrix Gla protein TXNIP thioredoxin interacting protein 
48 hours 
ACKR1 atypical chemokine receptor 
1 (Duffy blood group) 
LITAF lipopolysaccharide-induced 
TNF factor 
ADAMTS1 ADAM metallopeptidase with 
thrombospondin type 1 motif, 
1 
MACROD1 MACRO domain containing 1 
ADSSL1 adenylosuccinate synthase 
like 1 
MAP3K6 mitogen-activated protein 
kinase kinase kinase 6 
AK4 adenylate kinase 4 NAT6 N-acetyltransferase 6 (GCN5-
related) 
ALDOC aldolase C, fructose-
bisphosphate 
NOTCH3 notch 3 
ANGPTL4 angiopoietin-like 4 ODF3B outer dense fiber of sperm tails 
3B 
APOBEC3D apolipoprotein B mRNA 
editing enzyme, catalytic 
polypeptide-like 3D 
OPRL1 opiate receptor-like 1 
ASS1 argininosuccinate synthase 1 PIM1 Pim-1 proto-oncogene, 
serine/threonine kinase 
CACNG6 calcium channel, voltage-
dependent, gamma subunit 6 
PITPNM1 phosphatidylinositol transfer 
protein, membrane-associated 
1 
CADM3 cell adhesion molecule 3 PLEKHA4 pleckstrin homology domain 
containing, family A 
(phosphoinositide binding 
specific) member 4 
CDH4 cadherin 4, type 1, R-
cadherin (retinal) 
PTP4A3 protein tyrosine phosphatase 
type IVA, member 3 
CFB complement factor B RASSF4 Ras association (RalGDS/AF-
6) domain family member 4 
CPLX1 complexin 1 RCN3 reticulocalbin 3, EF-hand 
calcium binding domain 
EML2 echinoderm microtubule 
associated protein like 2 
RHOU ras homolog family member U 
ETV4 ets variant 4 RIN1 Ras and Rab interactor 1 
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Table 5 (continued)
FLNC filamin C, gamma SCN8A sodium channel, voltage gated, 
type VIII, alpha subunit 
FLT1 fms-related tyrosine kinase 1 SLC2A3 solute carrier family 2 
(facilitated glucose 
transporter), member 3 
GABBR2 gamma-aminobutyric acid 
(GABA) B receptor, 2 
SLCO2A1 solute carrier organic anion 





SOCS3 suppressor of cytokine 
signaling 3 
GRIN2D glutamate receptor, 
ionotropic, N-methyl D-
aspartate 2D 
SPAG4 sperm associated antigen 4 
HSPB6 heat shock protein, alpha-
crystallin-related, B6 
SPINT1 serine peptidase inhibitor, 
Kunitz type 1 
IGF2 insulin-like growth factor 2 
(somatomedin A) 
STC2 stanniocalcin 2 
INHBA inhibin, beta A TMEM8B transmembrane protein 8B 
ITGB4 integrin, beta 4 TXNIP thioredoxin interacting protein 
JAK3 Janus kinase 3 VHL von Hippel-Lindau tumor 
suppressor, E3 ubiquitin 
protein ligase 
LAMA5 laminin, alpha 5 ZC3H6 zinc finger CCCH-type 
containing 6 
associated protein like 2
ETV4 ets variant 4 PIM1 Pim-1 proto-oncogene, 
serine/threonine kinase
96 hours
ACKR1 atypical chemokine receptor 
1 (Duffy blood group)
KCNN3 potassium intermediate/small 
conductance calcium-activated 
channel, subfamily N, member 
3
ADAMTS4 ADAM metallopeptidase with 
thrombospondin type 1 motif, 
4
ITGB4 integrin, beta 4




AK4 adenylate kinase 4 MACROD1 MACRO domain containing 1
ALDH1A3 aldehyde dehydrogenase 1 
family, member A3
MS4A6A membrane-spanning 4-
domains, subfamily A, member 
6A
ALDOC aldolase C, fructose-
bisphosphate
MSMP microseminoprotein, prostate 
associated
ANGPTL4 angiopoietin-like 4 NOTCH3 notch 3
BDNF brain-derived neurotrophic 
factor
NPR3 natriuretic peptide receptor 3
CFB complement factor B P4HA1 prolyl 4-hydroxylase, alpha 
polypeptide I
COL6A2 collagen, type VI, alpha 2 PDE3A phosphodiesterase 3A, cGMP-
inhibited
CPLX1 complexin 1 PDIA5 protein disulfide isomerase 
family A, member 5
EML2 echinoderm microtubule PDLIM1 PDZ and LIM domain 1
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to the p38/mitogen-activated protein kinase (MAPK) 
pathway is shown to be differentially expressed only at 
48  h after putting ECs into coculture. This pathway is 
known to promote endothelial cell migration. The gene 
set related to transforming growth factor (TGF)-b is 
shown to be differentially expressed for at least some 
time points in both cocultures.
Discussion
Influence of brain pericytes on functional barrier 
properties: Barrier tightness and efflux transporter 
functionality
The tightening of junctions between human ECs, 
resulting in a decreased permeability to non-permeant 
markers, such as LY, is demonstrated to occur when 
ECs are cultivated with pericytes of either bovine (i.e. 
primary cells) or human (i.e. cell line) origin. This con-
firms the contribution of soluble factors secreted by 
brain pericytes in ECs barrier tightening. Therefore, 
this in  vitro set-up proved to be suitable for investi-
gation of the molecular mechanisms responsible for 
establishment of this important BBB feature in human 
ECs by RNA sequencing.
Influence of brain pericytes on the transcriptomic profile 
of brain‑like endothelial cells
Some important mechanisms involved in BBB estab-
lishment and maturation, notably the influence of brain 
pericytes, remain poorly understood. For this, we inves-
tigated transcriptional changes in ECs in soloculture 
compared to in ECs in coculture with brain pericytes.
Influence of pericytes on the global gene expression profile 
of brain‑like endothelial cells
Compared to the total number of identified genes, only 
few genes are differentially expressed when comparing 
Table 5 (continued)
GABBR2 gamma-aminobutyric acid 
(GABA) B receptor, 2





RASSF4 Ras association (RalGDS/AF-
6) domain family member 4
HMGN5 high mobility group 
nucleosome binding domain 
5
RHOU ras homolog family member U
HOXB8 homeobox B8 SCN8A sodium channel, voltage gated, 
type VIII, alpha subunit
HSP90B1 heat shock protein 90kDa 
beta (Grp94), member 1
SELP selectin P (granule membrane 
protein 140kDa, antigen 
CD62)
HSPA5 heat shock 70kDa protein 5 
(glucose-regulated protein, 
78kDa)
SERPING1 serpin peptidase inhibitor, 
clade G (C1 inhibitor), 
member 1
HSPB6 heat shock protein, alpha-
crystallin-related, B6




(serotonin) receptor 1D, G 
protein-coupled
SLC46A3 solute carrier family 46, 
member 3
IFITM2 interferon induced 
transmembrane protein 2
SOCS3 suppressor of cytokine 
signaling 3
IGF2 insulin-like growth factor 2 
(somatomedin A)
SPAG4 sperm associated antigen 4
IGFBP1 insulin-like growth factor 
binding protein 1
SPINT1 serine peptidase inhibitor, 
Kunitz type 1
INHBA inhibin, beta A TXNIP thioredoxin interacting protein
INHBB inhibin, beta B ZC3H6 zinc finger CCCH-type 
containing 6
FBLN2 fibulin 2 PRKAA2 protein kinase, AMP-activated, 
alpha 2 catalytic subunit
Shading colour highlights coculture enriched genes that are identified to be overlapping in two (light grey) or all time points (dark grey)
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solocultured and cocultured ECs. This result suggests 
that only a small percentage of genes is responsible for 
the observed barrier tightening in ECs. The number of 
differentially expressed genes between solo- and cocul-
ture is increasing with coculture duration. Indeed, this 
was expected as the EC monolayer was tighter after 
96 h in presence of pericytes than after 24 h.
Enriched gene expression
The increasing number of soloculture enriched genes 
over time, while the expression of those genes is not 
differentially regulated in the soloculture over time, 
might actually reflect their downregulation in the CBP 
and CHP. Indeed, the importance of downregulated 
genes in ECs, as an integral part of the BBB signature, 
was already pointed out by Daneman et  al. [10] while 
comparing BBB ECs with peripheral ECs in mice.
Although, some differences can be observed in the 
transcriptomic profile of the two cocultures, these dif-
ferences might simply reflect the differences between 
the two cell types (i.e. cell line for human pericytes vs. 
primary cells for bovine pericytes). Indeed, this was 
not the scope of our study. However, the fact that some 
genes are regulated in both cocultures, while compared 
to soloculture, reinforces the potential importance of 
those genes in the barrier tightening that was observed 
in both cocultures.
Although, the role of those genes should be fur-
ther evaluated using other techniques, some of them 
were already found to be relevant regarding the BBB in 
other studies. As an example, the Duffy antigen recep-
tor (ACKR1) is an interesting gene listed in the top 10 
of coculture enriched genes for both the CBP and the 
CHP at all time points. ACKR1 is a non-specific recep-
tor for several pro-inflammatory chemokines such as the 
chemokine (C-X-C motif ) ligand 2 (CXCL2) [17, 35]. One 
role of ACKR1 is to retain neutrophil-derived CXCL2 at 
the endothelial junctions to regulate its unidirectional 
migration across the venule wall. This has recently been 
demonstrated by a study of Girbl et al. [17]. However, the 
reason behind the observed high expression of ACKR1 
in cocultured ECs in this study will have to be further 
Fig. 5 Heat map of vascular genes, junction associated genes, tight junction and tight junction associated genes, ABC transporter genes and 
endothelial marker genes in endothelial cells. Data input consisted of the normalized expression in solocultured endothelial cells and the 
normalized expression in cocultured endothelial cells (i.e. with either human pericytes (CHP) or bovine pericytes (CBP). Unit variance scaling is 
applied to rows
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evaluated. It is likely that this is related to the secretion of 
CXCL1 by pericytes (and ECs), which on its turn forms 
a cue for neutrophils that are known to secrete CXCL2 
[17].
Another interesting gene is the bone morphogenetic 
protein endothelial cell precursor-derived regulator 
(BMPER) which is indicated as a soloculture enriched 
gene at several time points. The high expression of 
BMPER in solocultured ECs might be explained by its 
relation to forkhead box O 3a (FoxO3a), which is a tran-
scription factor involved in the regulation of endothelial 
permeability [25].
Gene expression profile of specific genes
The expression of BBB-related genes in ECs is not nec-
essarily depicting the main change upon pericyte induc-
tion, as for example genes that are known to increase 
vascular permeability, e.g. ANGPT2, PLVAP and ICAM1 
are demonstrated to be upregulated with a loss of peri-
cytes [10, 22]. Our data only partially reflects this as only 
some of these vascular-important genes are decreased, 
e.g. PLVAP, for which expression decreases drastically 
from 24 to 48 h and for ICAM1 and ANGPT1, which are 
genes known to increase permeability.
Tight junction proteins are important proteins known 
to regulate BBB permeability thereby restricting the par-
acellular pathway [13, 19, 20]. Our results show expres-
sion of several important tight junction genes and tight 
junction-associated genes, however, they are not char-
acterized by a drastic response upon presence of brain 
pericytes, although some show a visible response e.g. 
CLDN3, CLDN7, CLDN10. This stipulates the hypoth-
esis explained above of Daneman et al. [10] and confirms 
results from other studies [14].
Our data does therefore not directly lead to a conclu-
sive explanation that clarifies the observed difference in 
endothelial permeability for cocultured ECs compared 
to solocultured ECs, which suggests that the presence of 
pericytes alone does not define the BBB.
Fig. 6 Heatmap of all expressed solute carrier (SLC) transporters. Data input consisted of the normalized expression in solocultured endothelial 
cells and the normalized expression in cocultured endothelial cells (i.e. with either human pericytes (CHP) or bovine pericytes (CBP). Unit variance 
scaling is applied to rows
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Table 6 Top regulated soloculture enriched pathways at  24  h (top), 48  h (middle) and  96  h (bottom) for  (A) 
the  comparison of  soloculture vs. coculture with  human pericytes (CHP); and  for  (B) the  comparison of  soloculture vs. 
coculture with bovine pericytes (CBP)
Pathways in italic are soloculture enriched pathways identified in both comparisons for that specific time point. The 2nd column represents the ratio of upregulated 
and downregulated genes in the pathway under study (ratio ≥ 1.5)
A. B.
24 h 24 h
Pathway Ratio p‑value Pathway Ratio p‑value
 Post-Golgi vesicle mediated transport 1.7 1.10E−06    Regulation of cell morphogenesis involved in dif-
ferentiation
2.1 6.90E−04
 Regulation of programmed cell death 1.7 6.50E−06    Salivary gland morphogenesis 3.0 7.60E−04
 Regulation of cell death 1.7 8.70E−06    Salivary gland development 3.0 1.44E−03
 Regulation of apoptotic process 1.7 1.40E−05    Lysosomal transport 2.0 1.72E−03
 Golgi vesicle transport 1.8 1.90E−05    Establishment of protein localization to plasma 
membrane
3.3 2.66E−03
 Protein folding 1.7 4.10E−05    Protein localization to plasma membrane 2.0 2.94E−03
 Regulation of transcription from RNA polymerase II 
promotor in response to hypoxia
3.8 4.60E−05    Positive regulation of osteoblast proliferation 2.0 3.27E−03
 Negative regulation of cell death 1.9 5.40E−05    Plasma membrane organization 2.0 4.00E−03
 Negative regulation of programmed cell death 1.9 5.70E−05    Toll-like receptor 3 signaling pathway 1.6 5.24E−03
 De novo protein folding 2.0 6.60E−05    Exocrine system development 3.0 5.72E−03
48 h 48 h
 RNA export from nucleus 1.5 2.30E−05    RNA splicing, via transesterification reactions 4.3 9.20E−08
 mRNA export from nucleus 1.6 7.00E−05    mRNA splicing, via spliceosome 4.1 2.70E−07
 Post-Golgi vesicle-mediated transport 1.5 3.40E−04    RNA splicing, via transesterification reactions with 
bulged adenosine
4.1 2.70E−07
 Protein localization to endosome 7.0 5.80E−04    Regulation of cellular protein catabolic process 1.8 4.00E−07
 Type I interferon production 1.8 7.00E−04    Regulation of proteolysis involved in cellular protein 
catabolic process
1.9 5.80E−07
 Regulation of type I interferon production 1.8 7.00E−04    Positive regulation of cellular protein catabolic 
process
2.5 1.70E−06
 Regulation of monocyte differentiation 2.0 7.60E−04    mRNA metabolic process 2.2 2.50E−06
 Golgi localization 2.0 7.60E−04    Ribonucleoside triphosphate biosynthetic process 1.6 2.80E−06
 Protein K48-linked ubiquitination 1.6 1.00E−03    Positive regulation of proteolysis involved in cel-
lular protein catabolic process
2.7 3.40E−06
 Pyrimidine nucleotide metabolic process 1.8 1.46E−03    mRNA processing 2.6 4.20E−06
96 h 96 h
 Arp2/3 complex-mediated actin nucleation 2.0 7.50E−04    Positive regulation of protein ubiquitination 2.8 1.00E−05
 Pyrimidine nucleoside triphosphate metabolic 
process
1.8 1.01E−03    Positive regulation of ligase activity 3.9 1.90E−05
 Programmed necrotic cell death 4.5 1.88E−03    Positive regulation of protein modification by small 
protein conjugation or removal
2.6 2.00E−05
 Necroptotic process 9.0 2.59E−03    Nucleoside monophosphate metabolic process 2.2 2.70E−05
 Sprouting angiogenesis 2.0 3.53E−03    Positive regulation of ubiquitin-protein transferase 
activity
4.3 4.40E−05
 Regulation of necroptotic process 5.0 3.74E−03    Regulation of protein modification by small protein 
conjugation or removal
2.1 8.00E−05
 Fibroblast apoptotic process 2.0 3.74E−03    Regulation of protein ubiquitination 2.1 8.60E−05
 Deoxyribonucleotide biosynthetic process 4.0 4.17E−03    Ribonucleoside monophosphate metabolic 
process
1.9 1.10E−04
 Positive regulation of protein catabolic process 2.0 5.23E−03    Regulation of ligase activity 4.0 2.30E−04
 Positive regulation of protein modification by small 
protein conjugation or removal
1.8 5.81E−03    Positive regulation of execution phase of apoptosis 4.0 3.50E−04
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Influence of pericytes on signaling pathways in brain‑like 
endothelial cells
Although, focusing on individual genes might be an easy 
way to discover novel genes related to BBB formation 
and maintenance, it is essential to identify how different 
genes interact with each other in order to fully under-
stand the dynamic regulation of the BBB [5].
Therefore, pathway analysis is a valuable tool to find 
groups of functionally important genes [24]. Induction 
and formation occurs through a multiple-step process 
Table 7 Top 10 regulated coculture enriched pathways at  24  h (top), 48  h (middle) and  96  h (bottom) for  (A) 
the  comparison of  soloculture vs. coculture with  human pericytes (CHP); and  for  (B) the  comparison of  soloculture vs. 
coculture with bovine pericytes (CBP)
Pathways in italic are coculture enriched pathways identified in both comparisons for that specific time point. The 2nd column represents the ratio of upregulated and 
downregulated genes in the pathway under study (ratio ≥ 0.5)
A. B.
24 h 24 h
Pathway Ratio p‑value Pathway Ratio p‑value
 Formation of translation preinitiation complex 0.3 6.80E−05    Regulation of cell division 0.3 1.90E−05
 Endoplasmic reticulum calcium ion homeostasis 0.1 1.25E−03    Endothelial cell migration 0.3 2.20E−05
 Porphyrin-containing compound biosynthetic 
process
0.4 1.33E−03    Sprouting angiogenesis 0.4 2.80E−05
 Ribonucleoprotein complex assembly 0.4 2.31E−03    Protein localization to organelle 0.4 3.00E−05
 Tetrapyrrole biosynthetic process 0.4 3.38E−03    Blood vessel endothelial cell migration 0.4 3.50E−05
 Cytoskeleton-dependent cytokinesis 0.4 4.09E−03    Chromosome segregation 0.2 4.90E−05
 Pigment biosynthetic process 0.5 6.86E−03    Epithelial cell migration 0.5 1.10E−04
 Negative regulation of centrosome duplication 0.3 9.16E−03    Ameboidal-type cell migration 0.5 1.10E−04
 Negative regulation of endoplasmic reticulum cal-
cium ion concentration
0.3 9.16E−03    Viral life cycle 0.4 1.30E−04
 Negative regulation of centrosome cycle 0.3 9.16E−03    Tissue migration 0.5 1.30E−04
48 h 48 h
 Notch signaling pathway 0.5 4.60E−05    Epithelial cell migration 0.4 3.00E−04
 Hyaluronan catabolic process 0.1 4.50E−04    Epithelium migration 0.4 3.70E−04
 Nuclear-transcribed mRNA poly(A) tail shortening 0.4 5.90E−04    Tissue migration 0.4 3.70E−04
 Formation of translation preinitiation complex 0.2 9.50E−04    Cell junction assembly 0.4 4.20E−04
 Response to cold 0.3 2.90E−04    Regulation of cell migration involved in sprouting 
angiogenesis
0.3 5.20E−04
 mRNA catabolic process 0.5 3.19E−03    Regulation of sprouting angiogenesis 0.3 5.20E−04
 Autonomic nervous system development 0.2 4.49E−03    Regulation of blood vessel endothelial cell migration 0.2 5.30E−04
 Polysaccharide biosynthetic process 0.5 5.17E−03    Carbohydrate biosynthetic process 0.4 5.40E−04
 Lipopolysaccharide metabolic process 0.3 8.03E−03    Blood vessel endothelial cell migration 0.4 5.60E−04
 Lipopolysaccharide biosynthetic process 0.3 8.03E−03    Cell junction organization 0.4 6.10E−04
96 h 96 h
 Translational termination 0.0 6.80E−24    Notch signaling pathway 0.3 8.20E−05
 Nuclear-transcribed mRNA catabolic process 0.1 1.70E−22    Response to endoplasmic reticulum stress 0.4 8.20E−05
 Cotranslational protein targeting to membrane 0.0 1.60E−21    Peptidyl-proline hydroxylation 0.2 2.17E−03
 Protein targeting to ER 0.0 3.90E−21    Post-translational protein modification 0.3 2.17E−03
 SRP-dependent cotranslational protein targeting to 
membrane
0.0 4.70E−21    Positive regulation of gene expression (epigenetic) 0.3 2.91E−03
 Protein localization to endoplasmic reticulum 0.0 4.80E−21    Regulation of mRNA catabolic process 0.3 2.95E−03
 Establishment of protein localization to endoplasmic 
reticulum
0.0 2.10E−20    Maintenance of protein localization in organelle 0.1 3.35E−03
 Nuclear-transcribed mRNA catabolic process 0.1 4.10E−20    Maintenance of protein localization in endoplasmic 
reticulum
0.0 3.35E−03
 mRNA catabolic process 0.1 2.70E−19    Notch signaling involved in heart development 0.2 3.98E−03
 Translational initiation 0.1 1.00E−18    Vesicle targeting to, from or within Golgi 0.0 4.03E−03
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comprising a broad variety of signaling pathways, all 
directed by signals of different cell types. For example, 
vascular endothelial growth factor (VEGF)-related path-
ways such as the p38/MAPK pathway, play a key regula-
tive role in proliferation, survival and migration of ECs 
[30]. Other signaling pathways like TGF-b, Angpt 1 and 
2, notch and the phosphoinositide 3-kinase (PI3K) path-
way are essential for BBB development and maintenance, 
by supporting a pericyte function. The latter is demon-
strated by studies that show defective BBB formation 
upon pericyte absence [11, 22, 30].
Our results indicate significant association of mul-
tiple pathways expressed in ECs with the introduction 
of brain pericytes. However, the Wnt pathway, which 
is one of the most important pathways known to regu-
late BBB formation, does not show to be differentially 
expressed in ECs between solo- and cocultures. The 
Wnt pathway is known to induce BBB features such as 
the expression of tight junctions and expression of spe-
cific transporters (e.g. SLC2A1 or GLUT-1), and central 
nervous system-specific angiogenesis during embryo-
genesis [24, 30]. Except for SLC2A1, other Wnt-related 
genes known to be regulated by b-catenin (e.g. LEF1, 
APCDD1, AXIN2, STRA6, SLC2A1) are, at the con-
trary, only poorly expressed in our study [30]. Never-
theless, these results might just indicate an earlier time 
point of activation of this pathway than the time points 
considered within this study. This would be in line with 
the fact that induction of BBB properties is initiated 
by Wnt activation by neural precursors [5]. Consider-
ing the previous, we should be aware of the presence of 
other important pathways and signaling cascades that 
take place at an earlier time point than the first ana-
lysed time point in this study (i.e. 24 h).
Although, some important pathways were discov-
ered over the years, many of the molecular mechanisms 
behind pericyte-endothelial interactions or behind BBB 
formation and maintenance are yet to be discovered. The 
results obtained in this study might be used in further 
analysis.
Table 8 Top differentially expressed pathways for the comparison of soloculture vs. coculture with bovine pericytes (CBP) 
at 24 h
Pathway analysis was conducted using different databases i.e. KEGG pathway, Reactome and Panther [37]. Statistical analysis was performed using the Fisher’s exact 
test and false discovery rate correction test was performed by the Benjamini and Hochberg method [3]
Term Database Corrected p‑value
Osteoclast differentiation KEGG 8.46E−04
Regulation of insulin-like growth factor (IGF) transport and uptake by insulin-like growth 
factor binding proteins (IGFBPs)
Reactome 0.001
Cytokine Signaling In Immune System Reactome 0.002
Syndecan interactions Reactome 0.003
Extracellular matrix organization Reactome 0.004
TNF signaling pathway KEGG 0.004
Notch signaling pathway PANTHER 0.006
Immune system Reactome 0.006
Cell surface interactions at the vascular wall Reactome 0.012
Non-integrin membrane-ECM interactions Reactome 0.014
Interferon alpha/beta signaling Reactome 0.017
Interferon signaling Reactome 0.019
Hemostasis Reactome 0.020
ECM proteoglycans Reactome 0.022
Platelet degranulation Reactome 0.022
Response to elevated platelet cytosolic Ca2+ Reactome 0.024
Nicotine degradation PANTHER 0.028
Molecules associated with elastic fibers Reactome 0.029
Integrin cell surface interactions Reactome 0.030
Tryptophan metabolism KEGG 0.031
Hepatitis B KEGG 0.032
PECAM1 interactions Reactome 0.040
Elastic fiber formation Reactome 0.041
AGE-RAGE signaling pathway in diabetic complications KEGG 0.046
GRB2/SOS provides linkage to MAPK signaling for Integrins Reactome 0.047
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Table 9 Top differentially expressed pathways for  the  comparison of  soloculture vs. coculture with  human pericytes 
(CHP) at 24 h
Pathway analysis was conducted using different databases i.e. KEGG pathway, Reactome and Panther. Statistical analysis was performed using the Fisher’s exact test 
and false discovery rate correction test was performed by the Benjamini and Hochberg method [3]
Term Database Corrected 
p‑value
AGE-RAGE signaling pathway in diabetic complications KEGG 0.002
Hemostasis Reactome 0.002
Cell adhesion molecules (CAMs) KEGG 0.006
Senescence-associated secretory phenotype (SASP) Reactome 0.007
TNF signaling pathway KEGG 0.009
CCKR signaling map PANTHER 0.009
Cell surface interactions at the vascular wall Reactome 0.014
Chemokine signaling pathway KEGG 0.016
Osteoclast differentiation KEGG 0.022
Signaling by cytosolic FGFR1 fusion mutants Reactome 0.023
Syndecan interactions Reactome 0.025
Estrogen signaling pathway KEGG 0.032
Extracellular matrix organization Reactome 0.035
Propanoate metabolism KEGG 0.036
2-Oxobutanoate degradation BioCyc 0.037
Valine, leucine and isoleucine degradation KEGG 0.038
Integrin cell surface interactions Reactome 0.040
Immune system Reactome 0.047
Table 10 Top differentially expressed pathways for  the  comparison of  soloculture vs. coculture with  bovine pericytes 
(CBP) at 96 h
Pathway analysis was conducted using different databases i.e. KEGG pathway, Reactome and Panther. Statistical analysis was performed using the Fisher’s exact test 
and false discovery rate correction test was performed by the Benjamini and Hochberg method [3]
Term Database Corrected p‑value
Regulation of insulin-like growth factor (IGF) transport and uptake by insulin-like growth fac-
tor binding proteins (IGFBPs)
Reactome 3.31E−04
Gap junction assembly Reactome 0.003
Gap junction trafficking Reactome 0.008
Gap junction trafficking and regulation Reactome 0.008
Degradation of the extracellular matrix Reactome 0.012
Inhibition of voltage gated  Ca2+ channels via beta/gamma subunits Reactome 0.015
Activation of G protein gated potassium channels Reactome 0.015
G protein gated potassium channels Reactome 0.015
Cell cycle, mitotic Reactome 0.018
Cell cycle Reactome 0.020
Extracellular matrix organization Reactome 0.021
Inwardly rectifying  K+ channels Reactome 0.027
Phenylalanine metabolism KEGG 0.027
Deposition of new CENPA-containing nucleosomes at the centromere Reactome 0.038
Nucleosome assembly Reactome 0.038
Intrinsic pathway of fibrin clot formation Reactome 0.047
GABA B receptor activation Reactome 0.048
Activation of GABAB receptors Reactome 0.048
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Table 11 Top differentially expressed pathways for  the  comparison of  soloculture vs. coculture with  human pericytes 
(CHP) at 96 h
Pathway analysis was conducted using different databases i.e. KEGG pathway, Reactome and Panther. Statistical analysis was performed using the Fisher’s exact test 
and false discovery rate correction test was performed by the Benjamini and Hochberg method [3]
Term Database Corrected p‑value
RHO GTPase effectors Reactome 1.02E−04
DNA methylation Reactome 0.004
SIRT1 negatively regulates rRNA expression Reactome 0.005
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 Reactome 0.005
RHO GTPases activate formins Reactome 0.008
RNA polymerase I promoter opening Reactome 0.009
B-WICH complex positively regulates rRNA expression Reactome 0.010
RHO GTPases activate PKNs Reactome 0.0131
Signal Transduction Reactome 0.022
Formation of the beta-catenin/TCF transactivating complex Reactome 0.024
G1/S-specific transcription Reactome 0.026
Mineral absorption KEGG 0.032
Epigenetic regulation of gene expression Reactome 0.038
Extracellular matrix organization Reactome 0.041
Regulation of insulin-like growth factor (IGF) transport and uptake by insulin-like growth factor binding 
proteins (IGFBPs)
Reactome 0.046
Fig. 7 Pathway (PW) analysis of several BBB-related PWs for the comparison of solocultured vs. cocultured endothelial cells with (A) human 
pericytes (CHP); and with B) bovine pericytes (CBP) at different time points (i.e. 24, 48 and 96 h). The x-axis depicts the p-value. Data analysis was 
conducted using the GO enrichment tool of GenXPro
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Conclusion
BBB formation and maintenance are complexly regu-
lated by several pathways and signaling cascades, which 
are activated by different kind of signals. The processes 
are known to be regulated in a spatial–temporal man-
ner and involve the interaction of different cell types of 
the NVU and brain ECs [5]. Human in  vivo assessment 
of the molecular mechanisms behind BBB formation and 
maintenance is hampered by ethical and practical issues. 
However, well-designed in vitro models that use human 
cells from a different origin (e.g. stem cells) can greatly 
benefit this research because of their non-invasiveness 
and ‘easy-to-handle’-characteristics. They also circum-
vent the many obstacles related to the use of primary 
human brain cells which is evidenced by the cumbersome 
extraction of pure brain capillary ECs out of human brain 
tissue [24]. Although, advancements over the last years 
in purification techniques (e.g. fluorescence-activated 
cell sorting and magnetic bead immunoprecipitation) 
do enhance research possibilities, and in  vitro models 
using human stem cells are still beneficial as availability 
of healthy human brain tissue is scarce. In vitro models 
allow to focus on the interaction between ECs and other 
cell types of the NVU, thereby decomposing the contri-
bution of different elements of the NVU. Of course, it 
should be emphasized that this type of studies does not 
represent the whole BBB physiology, as it lacks several 
components like the extracellular matrix or other cell 
types of the NVU, however, the use of these in vitro BBB 
models in RNA sequencing analysis can reveal enriched 
genes and pathways that are involved in the response of 
ECs to paracrine signals delivered by brain pericytes. 
Besides lacking physiological parameters, sequencing of 
additional samples would ameliorate the statistical power 
for identification of significantly differentially expressed 
genes. Unlike qRT-PCR, RNA sequencing allows the 
evaluation of all potential important genes as the method 
does not rely on the use of specific probes for detection 
of initially chosen genes [34].
This study therefore performed RNA sequencing 
(MACE) of ECs derived from cord-blood hematopoi-
etic stem cells that were cultured in absence (i.e. solo-
culture) or presence (i.e. coculture) of brain pericytes. 
Comparison of both transcriptomes resulted in the 
identification of a set of upregulated genes in solocul-
ture conditions (soloculture enriched genes) and a set 
of upregulated genes in coculture conditions (coculture 
enriched genes). Thereby, several typical BBB genes 
showed an upregulation, as well as several typical vas-
cular genes showed a downregulation in coculture 
conditions.
Besides transcriptomics, all other types of ‘omics’ 
(e.g. proteomics, metabolomics and lipidomics) can be 
complementary used to provide crucial details on the 
actual output of these enriched genes as it is known 
that transcript abundance show low correspondence to 
protein level [24]. Integration of these different types of 
datasets can result in a more comprehensive image of the 
BBB vasculature [24, 38]. Therefore, the transcriptomic 
datasets that resulted from this study provide a starting 
point to discover the mechanisms behind BBB forma-
tion and maintenance for further validation of interest-
ing soloculture and coculture enriched genes or for micro 
RNA (miRNA) analysis. miRNAs are known to be capa-
ble of individually regulating many mRNA transcripts by 
mRNA degradation or inhibition of protein translation 
[31]. Several studies thereby evidence an important role 
of endogenous miRNAs in the regulation of BBB func-
tion [26]. Preliminary evaluation of miRNA expression, 
for which data is not shown, resulted in the identification 
of some specific significantly altered miRNAs. Analysis 
of target genes regulated by these miRNAs subsequently 
identified a number solo- or coculture enriched tran-
scripts, which suggests importance of miRNA in the 
regulation of enriched genes. Further analysis, that 
links dysregulated miRNA expression to differentially 
expressed genes that are likely related to BBB formation 
and maintenance, might therefore be essential to provide 
a complete understanding of the regulation of important 
BBB genes.
The number of transcriptomic profiling studies of the 
endothelial barriers, including the BBB, and vasculature 
in general, did drastically increase over the last years. 
The latter resulted in the development of transcriptomic 
databases [38]. The power of these databases is underes-
timated as they bear a massive amount of valuable data. 
Although comparative studies of transcriptomic data can 
be trivial, it may further delineate the molecular mecha-
nisms behind BBB formation and BBB maintenance.
Within the framework of the European Brain Bar-
riers Training Network (H2020-MSCA-ITN-2015), 
called BtRAIN, a BBBHub (Interfaculty Bioinformat-
ics Unit, UBern, Switzerland) is currently being devel-
oped in order to collect and disseminate transcriptomic 
(resulting from RNA sequencing) data from a variety of 
studies (in vitro and in  vivo, across different species). 
The transcriptomic data generated in this study will 
be available in this BBBHub (http://bbbhu b.unibe .ch/) 
upon launch which will allow further use of this data 
in comparative cross-species and cross-system analy-
sis, due to homogeny of the data analysis process and 
the presence of substantial metadata. This will further 
validate the data obtained in this study. For example, a 
drawback of the present study is the sole analysis of the 
BBB in static conditions, as the experimental design is 
lacking physiological parameters such as mechanical 
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forces (e.g. shear stress). The latter is demonstrated to 
increase the ECs expression of cytoskeletal genes [24]. 
It would therefore be valuable to compare genes that 
were found to be enriched in the present study to the 
transcriptomic profile of cocultured ECs in dynamic, 
flow conditions. However, caution should be made 
when comparing datasets from different studies as dif-
ferent experimental conditions with different variables 
pose a challenge for generating conclusive interpreta-
tions e.g. inter-individual and regional variability [4, 
38].
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